Stephan Goldenbaum has worked in biotech since 2003. Until 2017, he was head of sales in Europe, Africa and the Middle East working for QIAGEN, a leading global biotech company. From 2018 until joining Solis BioDyne, Goldenbaum worked on developing sales channels in the large Germany-based biotech company Eppendorf Group. Goldenbaum holds Master’s degrees in biology and business integration.
According to Stephan Goldenbaum, he considers his task to be the improvement of Solis BioDyne’s product development and sales, growing the company’s export volumes and expanding its network of partnerships. “We operate in the market of reagents, where export volumes are measured in millilitres. This means even more work needs to be done in research and development, that drives export. We want to work even more closely with research institutions, primarily the University of Tartu with whom we already have close relations. Solis BioDyne wants to continue to be one of the most attractive employers in Estonia for students and scientists of life-sciences. For example, we are very interested in recruiting people trained in biotechnology, chemistry, gene technology and bioanalytics,” says Goldenbaum.
Solis BioDyne is also preparing to build a larger and more modern new office and production building on Palsa Street in Tartu. “We are starting to outgrow our current premises in Tartu Science Park because our staff and production volumes have multiplied over the past couple of years. We hope to move into the new building equipped with a state-of-the-art biotech research and development unit in a year’s time,” explains Goldenbaum.
Salim Essakali, who also has long-term experience from the biotechnology company QIAGEN and the manufacturer of medical devices Boston Scientific, will also start working as the Head of Global Sales and Marketing of Solis BioDyne on September 1. 2021.
He has conducted his Master of Science in Molecular Pathology, holds an MBA in Corporate Strategy, and has extensive management experience developing, commercializing, and life-cycle-managing in BioTech and MedTech field.
OÜ Solis BioDyne operating in Tartu Science Park is one of Estonia’s leading biotech companies developing and producing reagents. DNA polymerases, PCR Master Mixes, qPCR Mixes and reverse transcription reagents are highly valued across the globe. Majority of its exports end up in Europe and the United States of America. Solis BioDyne uses unique genetic modification within all products to make them stable at room temperature for 30 days, to provide more sustainable and cost-effective solutions. The company was established in 1995 and now employs over 60 people.
Further information:
Sigrid HänniMarketing and Communication ManagerSOLIS BIODYNE OÜA: Teaduspargi 9, 50411 Tartu, EstoniaT: +372 5682 5751E: sigrid.hanni@solisbiodyne.comW: www.solisbiodyne.com
It doesn’t happen often that products developed almost three decades ago remain not only on the product list but as one of the most popular products overall. This is, however, the case with our main polymerases. These have become classics that seem to never go out of style like jeans or a little black dress. So, what makes them so special? Let’s take a look!
Every company has to start from somewhere. There can either be an “aha” moment - a sudden spark of inspiration that sets everything in motion. Other times it can happen gradually with ideas coming and going until something bigger grows out of all this brainstorming. For Solis BioDyne, it was the latter. As we celebrate 30 years since our founding, we think it’s the perfect time to share our origin story with you.
Have you ever thought about doing a PCR experiment, but you are not quite sure what product to use? Or the product you have chosen doesn’t work as well as it should and you are looking for an alternative? We are here to help you out with some recommendations from fellow scientists based on different application possibilities.
For 10 years now, on the 11th of February, we celebrate the women and girls who have chosen to follow the path of science. We believe giving everyone a chance to do what they love is important, and it doesn’t matter what gender a person is. In Solis BioDyne, 66% of our employees and 75% of our scientists are women and they are absolutely amazing in their work.
